Amylin + GLP-1 Blend
Cagrilintide + Semaglutide
VANTA-CAGRILINTIDE-SEMAGLUTIDE
Weight Management
Cagrilintide + Semaglutide research blend studied for complementary metabolic and appetite pathways. ≥99% purity, third-party tested, batch COA included.
Vial Size10mg
Out of stock
Subscribe & Save
$200
$200
Sun, Jul 19 - Thu, Jul 23
Free shipment protection
Overnight shipping available
We accept
Pay
VISA
DISC
AMEX
For laboratory and research use only. Not for human or veterinary consumption, and not for diagnostic or therapeutic use. These statements have not been evaluated by the FDA.
Product Details
This research blend combines Cagrilintide, a long-acting amylin analog, with Semaglutide, a GLP-1 receptor agonist.
The pairing is studied for complementary metabolic and satiety signaling — amylin and GLP-1 act through distinct pathways, making the combination a focus of appetite- and weight-regulation research.
Specs: ≥99% purity · lyophilized · batch-specific COA (HPLC + mass spec).
